{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T01:47:08Z","timestamp":1776476828523,"version":"3.51.2"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T00:00:00Z","timestamp":1525910400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"American Society for Biochemistry and Molecular Biology (US)"},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R15CA104014"],"award-info":[{"award-number":["R15CA104014"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000997","name":"Arnold and Mabel Beckman Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000997","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hope College REACH Program"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0196760","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T13:34:02Z","timestamp":1525959242000},"page":"e0196760","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["CUL5 is required for thalidomide-dependent inhibition of cellular proliferation"],"prefix":"10.1371","volume":"13","author":[{"given":"Bryan","family":"Kunkler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Salamango","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary J.","family":"DeBruine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin","family":"Ploch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirley","family":"Dean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Grossens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"Hledin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel A.","family":"Marquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Madden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abigayle","family":"Schnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Short","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2962-7424","authenticated-orcid":true,"given":"Maria A.","family":"Burnatowska-Hledin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,5,10]]},"reference":[{"key":"ref1","first-page":"1198","article-title":"Expression cloning of an AVP-activated calcium-mobilizing receptor from rabbit kidney medulla","volume":"268","author":"M Burnatowska-Hledin","year":"1995","journal-title":"Am J Physiol"},{"key":"ref2","first-page":"2","article-title":"Identification and analysis of expression of human VACM-1, a cullin gene family member located on chromosome 11q22-23","volume":"7","author":"PJ Byrd","year":"1997","journal-title":"Genome Research"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"6634","DOI":"10.1128\/MCB.16.12.6634","article-title":"Cdc53p acts in concert with Cdc4p and Cdc34p to control the G<sub>1<\/sub>to-S-phase transition and identifies a conserved family of proteins","volume":"16","author":"N Mathias","year":"1996","journal-title":"Mol Cell Biol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0092-8674(00)81267-2","article-title":"Cul-1 is required for cell cycle exit in C. elegans and identifies a novel gene family","volume":"85","author":"ET Kipreos","year":"1996","journal-title":"Cell"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrm1547","article-title":"Function and regulation of cullin-ring ubiquitin ligases","volume":"6","author":"MD Petroski","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1600-0854.2005.00294.x","article-title":"E3 ubiquitin ligases as regulators of membrane protein trafficking and degradation","volume":"6","author":"D\u2019Azzo","year":"2005","journal-title":"Traffic"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"28557","DOI":"10.1074\/jbc.272.45.28557","article-title":"Characterization of NEDD8, a developmentally down-regulated ubiquitin-like protein","volume":"272","author":"T Kamitani","year":"1997","journal-title":"J Biol Chem"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.1038\/sj.onc.1203093","article-title":"Covalent modification of all members of human cullin family proteins by NEDD8","volume":"18","author":"T Hori","year":"1999","journal-title":"Oncogene"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.molcel.2008.08.021","article-title":"Multimodal activation of the ubiquitin ligase SCF by Nedd8 conjugation","volume":"32","author":"A Saha","year":"2008","journal-title":"Mol Cell"},{"key":"ref10","first-page":"F199","article-title":"VACM-1 receptor is specifically expressed in rabbit vascular endothelium and renal collecting tubule","volume":"276","author":"M Burnatowska-Hledin","year":"1998","journal-title":"Am J Physiol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1126\/science.1089591","article-title":"Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex","volume":"302","author":"X Yu","year":"2003","journal-title":"Science"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"9579","DOI":"10.1128\/JVI.79.15.9579-9587.2005","article-title":"Regulation of Apobec3F and human immunodeficiency virus type 1 Vif by Vif-Cul5-ElonB\/C E3 ubiquitin ligase","volume":"79","author":"B Liu","year":"2005","journal-title":"J. Virol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1101\/gad.926401","article-title":"Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a cullin-containing complex","volume":"15","author":"E Querido","year":"2001","journal-title":"Genes Dev"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"20330","DOI":"10.1073\/pnas.0810571106","article-title":"Regulation of HSP90 client proteins by a Cullin-5 RING E3 ubiquitin ligase","volume":"106","author":"ES Ehrlich","year":"2009","journal-title":"PNAS"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1101\/gad.1604207","article-title":"Cullin 5 regulates Dab1 protein levels and neuron positioning during cortical development","volume":"21","author":"L Feng","year":"2007","journal-title":"Genes Dev"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"5468","DOI":"10.1074\/jbc.M413040200","article-title":"ASB2 is an elongin BC-interacting protein tha can assemble with cullin5 and Rbx1 to reconstitute an E3 ubiquitin ligase complex","volume":"280","author":"ML Heuze","year":"2005","journal-title":"J. Biol Chem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1038\/sj.emboj.7601781","article-title":"XRab40 and XCullin5 form a ubiquitin ligase complex essential for the noncanonical Wnt pathway","volume":"26","author":"RH Lee","year":"2007","journal-title":"EMBO"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1096\/fj.06-7241com","article-title":"Adenovirus E4orf6 assembles with cullin5-ElonginB-ElonginC E3 ubiquitin ligase through an HIV\/SIV, Vif-like BC-box to regulate p53","volume":"21","author":"K Luo","year":"2007","journal-title":"FASEB J"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1476-4598-2-40","article-title":"Analysis of cul-5 expression in breast epithelial cells, breast cancer cell lines, normal tissues and tumor tissues","volume":"2","author":"MJ Fay","year":"2003","journal-title":"Mol Cancer"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.ejca.2007.02.005","article-title":"Analysis of 11q22-q23 deletion target genes in B-cell chronic lymphocytic leukaemia: evidence for a pathogenic role of NPAT, CUL5, and PPP2R1B","volume":"43","author":"C Kalla","year":"2007","journal-title":"Eur J Cancer"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.canlet.2012.02.038","article-title":"MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5","volume":"322","author":"XM Xu","year":"2012","journal-title":"Cancer Lett"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.bbrc.2004.05.057","article-title":"T47D breast cancer cell growth is inhibited by expression of VACM-1, a cul-5 gene","volume":"319","author":"M Burnatowska-Hledin","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.mvr.2007.08.004","article-title":"Expression of VACM-1\/CUL5 mutant in endothelial cells induces MAPK phosphorylation and maspin degradation and converts cells to the angiogenic phenotype","volume":"55","author":"A Buchwalter","year":"2008","journal-title":"Microvascular Research"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"C1386","DOI":"10.1152\/ajpcell.00338.2002","article-title":"VACM-1, a cul-5 gene, inhibits cellular growth by a mechanism that involves MAPK and p53 signaling pathways","volume":"285","author":"C Van Dort","year":"2003","journal-title":"Am J Physiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00441-012-1419-3","article-title":"VACM-1\/cul5 expression in vascular tissue in vivo is induced by water deprivation and its expression in vitro regulates aquaporin-1 concentrations","volume":"349","author":"AE Johnson","year":"2012","journal-title":"Cell Tissue Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cub.2008.12.007","article-title":"Restriction of Src activity by cullin-5","volume":"19","author":"GS Laszlo","year":"2009","journal-title":"Curr Biol"},{"key":"ref27","first-page":"683","article-title":"E3 ubiquitin ligase Cullin 5 modulates multiple molecular and cellular responses to heat shock protein 90 inhibition in human cancer cells","volume":"11","author":"RS Samant","year":"2014","journal-title":"Proc Nat Acad Sci USA"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"9855","DOI":"10.1073\/pnas.1733908100","article-title":"Targeted disruption of p185\/Cul7 gene results in abnormal vascular morphogenesis","volume":"100","author":"T Arai","year":"2003","journal-title":"Proc Nat Acad Sci"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s11626-008-9163-4","article-title":"Granulocytic differentiation of HL-60 promyelocytic leukemia cells is associated with increased expression of Cul5","volume":"45","author":"SS Baxter","year":"2009","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","article-title":"Thalidomide is an Inhibitor of Angiogenesis","volume":"91","author":"RJ D'Amato","year":"1994","journal-title":"Proc Nat Acad Sci USA"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/bies.200900103","article-title":"Thalidomide-induced limb defects: resolving a 50-year-old puzzle","volume":"31","author":"N Vargesson","year":"2009","journal-title":"BioEssays"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/bdra.20597","article-title":"The Effect of Thalidomide in Chicken Embryos","volume":"85","author":"TD Stephens","year":"2009","journal-title":"Birth Defects Research"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.0901505106","article-title":"Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation","volume":"106","author":"C Therapontos","year":"2009","journal-title":"PNAS"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1096\/fj.06-7603com","article-title":"Thalidomide induces limb deformation by perturbing the Bmp\/Dkk1\/Wnt signaling pathway","volume":"21","author":"J Knobloch","year":"2007","journal-title":"FASEB J"},{"key":"ref35","first-page":"323","article-title":"Thalidomide affects the skeletal system of young rats","volume":"70","author":"I Kaczmarczyk-Sedlak","year":"2013","journal-title":"Acta Polonia Pharmaceutica"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"G167","DOI":"10.1152\/ajpgi.00385.2009","article-title":"Thalidomide inhibits inflammatory and angiogenic activation of human intestinal microvascular endothelial cells (HIMEC)","volume":"298","author":"P Rafiee","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2121-7-17","article-title":"Thalidomide attenuates nitric oxide mediated angiogenesis by blocking migration of endothelial cells","volume":"7","author":"K Tamilarsan","year":"2006","journal-title":"BMC Cell Biol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"5334","DOI":"10.1200\/JCO.2005.03.723","article-title":"Thalidomide downregulates angiogenic genes in bome marrow endothelial cells of patients with active multiple myeloma","volume":"23","author":"A Vacca","year":"2005","journal-title":"J Clinical Oncology"},{"key":"ref39","first-page":"1","article-title":"Thalidomide-analogue biology: immunological, molecular and epigenetic targets in cancer therapy","author":"J Short","year":"2013","journal-title":"Oncogene"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1126\/science.1177319","article-title":"Identification of a Primary Target of Thalidomide Teratogenicity","volume":"327","author":"T Ito","year":"2010","journal-title":"Science"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1244851","article-title":"Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells","volume":"343","author":"J Kr\u00f6nke","year":"2014","journal-title":"Science"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1126\/science.1244917","article-title":"The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins","volume":"343","author":"G Lu","year":"2014","journal-title":"Science"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1182\/blood-2011-05-356063","article-title":"Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide","volume":"118","author":"YX Zhu","year":"2011","journal-title":"Blood"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1182\/blood-2012-06-438101","article-title":"High cerebron expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance","volume":"121","author":"A Broyl","year":"2013","journal-title":"Blood"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/10623320109063157","article-title":"Expression of VACM-1 protein in cultured rat adrenal endothelial cells is linked to the cell cycle","volume":"8","author":"M Burnatowska-Hledin","year":"2001","journal-title":"Endothelium"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1074\/jbc.M109.085225","article-title":"Phosphorylation of VACM-1\/Cul5 by protein kinase A regulates its neddylation and antiproliferative effect","volume":"285","author":"SE Bradley-Dean","year":"2010","journal-title":"J Biol Chem"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1365-2141.2001.02738.x","article-title":"Microvessel overexpression of aquaporin 1 parallels bone marrow angiogenesis in patients with active multiple myeloma","volume":"113","author":"A Vacca","year":"2001","journal-title":"Br J Haematol"},{"key":"ref48","first-page":"1149","article-title":"Heterogeneous expression of the aquaporin 1 (AQP1) water channel in tumors of the prostate, breast, ovary, colon and lung: a study using high density multiple human tumor tissue microarrays","volume":"26","author":"A Mobasheri","year":"2005","journal-title":"Int J Oncol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nature03460","article-title":"Impairment of angiogenesis and cell migration by targeted aquaporin-1 gene disruption","volume":"434","author":"S Saadoun","year":"2005","journal-title":"Nature"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.eururo.2008.10.014","article-title":"Expression of aquaporin 1 in primary renal tumors: a prognostic indictor of clear-cell renal cell carcinoma","volume":"56","author":"Y Huang","year":"2009","journal-title":"Eur Urol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"16084","DOI":"10.1074\/jbc.M710223200","article-title":"CUL2 is required for the activity of hypoxia-inducible factor and vasculogenesis","volume":"283","author":"Y Maeda","year":"2008","journal-title":"J Biol Chem"},{"issue":"1093","key":"ref52","first-page":"1","article-title":"Zebrafish CUL4A, but not CUL4B, modulates cardiac and forelimb development by upregulating tbx5a expression","volume":"10","author":"X Zhao","year":"2014","journal-title":"Hum Mol Genet"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1371\/journal.pgen.0030019","article-title":"Polymorphisms of CUL5 are associated with CD4+ T cell loss in HIV-1 infected individuals","volume":"3","author":"P An","year":"2007","journal-title":"PLoS Genet"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1073\/pnas.90.13.5974","article-title":"Thalidomide inhibits the replication of human immunodeficiency virus type 1","volume":"90","author":"S Makonkawekeyoon","year":"1993","journal-title":"Proc Nat Acad Sci"},{"key":"ref55","article-title":"Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia","volume":"1","author":"RT Swords","year":"2010","journal-title":"Blood"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nature07884","article-title":"An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer","volume":"458","author":"TA Soucy","year":"2009","journal-title":"Nature"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0196760","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T01:25:59Z","timestamp":1540344359000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0196760"}},"subtitle":[],"editor":[{"given":"Arie","family":"Horowitz","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,5,10]]},"references-count":56,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0196760","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,10]]}}}